MedTrace Logo

Pharmacological Treatment of Rett Syndrome With Statins

NCT02563860 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-07-12

Study results available
· View outcomes & findings →

Summary

This is a phase 2 , open label, dose escalating study of Lovastatin in Rett syndrome.

Conditions

Interventions

DRUG

Lovastatin

dose escallating

Sponsors & Collaborators

  • Rett Syndrome Research Trust

    collaborator OTHER

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Aleksandra Djukic, MD PhD · Montefiore Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02563860 on ClinicalTrials.gov